Publicaciones (15) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

    Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88

  2. Agonist antibodies to TNFR molecules that costimulate T and NK cells

    Clinical Cancer Research, Vol. 19, Núm. 5, pp. 1044-1053

  3. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein

    Cancer Research, Vol. 73, Núm. 1, pp. 139-149

  4. Better performance of CARs deprived of the PD-1 brake

    Clinical Cancer Research, Vol. 19, Núm. 20, pp. 5546-5548

  5. CD28 aptamers as powerful immune response modulators

    Molecular Therapy - Nucleic Acids, Vol. 2, pp. e98

  6. Cell tracking using multimodal imaging

    Contrast Media and Molecular Imaging, Vol. 8, Núm. 6, pp. 432-438

  7. Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination

    Clinical Cancer Research, Vol. 19, Núm. 5, pp. 997-1008

  8. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model

    Clinical Cancer Research, Vol. 19, Núm. 22, pp. 6151-6162

  9. Células dendríticas especializadas en presentación de antígenos exógenos a linfocitos T citotóxicos

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 3, pp. 519-537

  10. Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb

    Journal for ImmunoTherapy of Cancer, Vol. 1

  11. High-density lipoproteins delivering interleukin-15

    OncoImmunology, Vol. 2, Núm. 4

  12. Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodes

    Frontiers in Immunology, Vol. 4, Núm. DEC

  13. Interleukin-15 in gene therapy of cancer

    Current Gene Therapy, Vol. 13, Núm. 1, pp. 15-30

  14. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes

    Journal of Immunology, Vol. 190, Núm. 12, pp. 6694-6706

  15. Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

    Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944